<DOC>
	<DOCNO>NCT01733979</DOCNO>
	<brief_summary>The investigator perform 4-week , randomize , double-blind , placebo-controlled human trial evaluate efficacy safety Heme-Iron Polypeptide Improvement Anemia . The investigator measure Improvement Anemia parameter , include hemoglobin , transferrin saturation , serum iron , ferritin , monitor blood pressure .</brief_summary>
	<brief_title>Efficacy Safety Heme-Iron Polypeptide Improvement Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Males female 1960 year old Hemoglobin concentration le 13g/dL ( men ) , 12g/dL ( woman ) Able give inform consent Allergic hypersensitive ingredient test product History reaction test product gastrointestinal disease Crohn 's disease gastrointestinal surgery Participation clinical trial within past 2 month History alcohol substance abuse Laboratory test , medical psychological condition deem investigator interfere successful participation study Pregnant lactate woman etc .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>